Labo Euromedis (XPAR:ALEMG) Other Net Income (Loss) : €-8.28 Mil (TTM As of Jun. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Labo Euromedis Other Net Income (Loss)?

Labo Euromedis's Other Net Income (Loss) for the six months ended in Jun. 2023 was €-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 was €-8.28 Mil.

Labo Euromedis's quarterly Other Net Income (Loss) increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€0.02 Mil) but then declined from Dec. 2022 (€0.02 Mil) to Jun. 2023 (€-0.00 Mil).

Labo Euromedis's annual Other Net Income (Loss) increased from Dec. 2020 (€-0.12 Mil) to Dec. 2021 (€0.01 Mil) and increased from Dec. 2021 (€0.01 Mil) to Dec. 2022 (€0.02 Mil).

Labo Euromedis Other Net Income (Loss) Historical Data

The historical data trend for Labo Euromedis's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labo Euromedis Other Net Income (Loss) Chart

Labo Euromedis Annual Data

Trend

Jul13

Jul14

Jul15

Jul16

Jul17

Dec19

Dec20

Dec21

Dec22

Dec23

Other Net Income (Loss)

Get a 7-Day Free Trial

0.15

-0.12

0.01

0.02

-8.28

Labo Euromedis Semi-Annual Data
	Jul13	Jan14	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Net Income (Loss)	Get a 7-Day Free Trial															0.03	-	0.02	-	-8.28

Labo Euromedis Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-8.28 Mil.

Labo Euromedis Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Labo Euromedis's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Labo Euromedis (XPAR:ALEMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Labo Euromedis (XPAR:ALEMG) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

61R:Germany

Address

ZI de la Tuilerie, Neuilly-sous-Clermont, FRA, 60290

Website

https://www.euromedis.fr

Euromedis Groupe is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.

Labo Euromedis (XPAR:ALEMG) Headlines

No Headlines